AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

STRATEC SE

Declaration of Voting Results & Voting Rights Announcements Sep 18, 2009

416_dva_2009-09-18_a8cbbb4b-cd09-4a20-934d-0160dcb803d8.html

Declaration of Voting Results & Voting Rights Announcements

Open in Viewer

Opens in native device viewer

News Details

Voting Rights Announcements | 18 September 2009 17:15

STRATEC Biomedical Systems AG: Release according to Article 26, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

STRATEC Biomedical Systems AG / Release of an announcement according to Article 21, Section 1 of the WpHG [the German Securities Trading Act] (share)

18.09.2009

Dissemination of a Voting Rights announcement, transmitted by
DGAP - a company of EquityStory AG.
The issuer is solely responsible for the content of this announcement.


Threadneedle Asset Management Holdings Limited, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Threadneedle Asset Management Holdings Limited pursuant to § 22 para. 1
sent. 1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held
directly by Threadneedle Investment Funds ICVC and other funds.

Threadneedle Asset Management Holdings SARL, London, UK, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Threadneedle Asset Management Holdings SARL pursuant to § 22 para. 1
sent. 1 No. 6, sent. 2 and sent. 3 WpHG. These voting rights are held
directly by Threadneedle Investment Funds ICVC and other funds.

Ameriprise Financial, Inc., Minneapolis, Minnesota, USA, has notified us
pursuant to § 21 sec. 1 WpHG on 16 September 2009, that on 14 September
2009 the share of voting rights in STRATEC Biomedical Systems AG,
Birkenfeld, Germany, ISIN: DE0007289001 went above the threshold of 10% and
that the percentage of voting rights on that day amounted to 10.016%
(1,145,955 shares). These voting rights are in their entirety attributable
to Ameriprise Financial, Inc. pursuant to § 22 para. 1 sent. 1 No. 6, sent.
2 and sent. 3 WpHG. These voting rights are held directly by Threadneedle
Investment Funds ICVC and other funds.

Ameriprise Financial Inc. is the parent company of Threadneedle Asset
Management Holdings SARL which is the parent company of Threadneedle Asset
Management Holdings Limited.

18.09.2009 Financial News transmitted by DGAP


Language: English
Company: STRATEC Biomedical Systems AG
Gewerbestraße 37
75217 Birkenfeld
Deutschland
Internet: www.stratec-biomedical.de

End of News DGAP News-Service


Talk to a Data Expert

Have a question? We'll get back to you promptly.